Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to…
Immunocore Holdings plc, a commercial-stage biotechnology company pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients with…
Read More...
Read More...